BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 30476497)

  • 1. Modeling Human Digestive Diseases With CRISPR-Cas9-Modified Organoids.
    Fujii M; Clevers H; Sato T
    Gastroenterology; 2019 Feb; 156(3):562-576. PubMed ID: 30476497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression.
    Seino T; Kawasaki S; Shimokawa M; Tamagawa H; Toshimitsu K; Fujii M; Ohta Y; Matano M; Nanki K; Kawasaki K; Takahashi S; Sugimoto S; Iwasaki E; Takagi J; Itoi T; Kitago M; Kitagawa Y; Kanai T; Sato T
    Cell Stem Cell; 2018 Mar; 22(3):454-467.e6. PubMed ID: 29337182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
    Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R
    STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut organoids: mini-tissues in culture to study intestinal physiology and disease.
    Almeqdadi M; Mana MD; Roper J; Yilmaz ÖH
    Am J Physiol Cell Physiol; 2019 Sep; 317(3):C405-C419. PubMed ID: 31216420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential cancer mutations in cultured human intestinal stem cells.
    Drost J; van Jaarsveld RH; Ponsioen B; Zimberlin C; van Boxtel R; Buijs A; Sachs N; Overmeer RM; Offerhaus GJ; Begthel H; Korving J; van de Wetering M; Schwank G; Logtenberg M; Cuppen E; Snippert HJ; Medema JP; Kops GJ; Clevers H
    Nature; 2015 May; 521(7550):43-7. PubMed ID: 25924068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists.
    Fusco N; Bosari S
    World J Gastroenterol; 2016 Sep; 22(35):7926-37. PubMed ID: 27672288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of Autism Using Organoid Technology.
    Choi H; Song J; Park G; Kim J
    Mol Neurobiol; 2017 Dec; 54(10):7789-7795. PubMed ID: 27844287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids.
    Ramakrishna G; Babu PE; Singh R; Trehanpati N
    Hepatol Int; 2021 Dec; 15(6):1309-1317. PubMed ID: 34596864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
    González F
    Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Mediated Genome Editing of Mouse Small Intestinal Organoids.
    Schwank G; Clevers H
    Methods Mol Biol; 2016; 1422():3-11. PubMed ID: 27246017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a CRISPR Picture: Use of CRISPR/Cas9 to Model Diseases in Human Stem Cells In Vitro.
    Freiermuth JL; Powell-Castilla IJ; Gallicano GI
    J Cell Biochem; 2018 Jan; 119(1):62-68. PubMed ID: 28544217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of kidney organoids derived from human pluripotent stem cells.
    Kim YK; Nam SA; Yang CW
    Korean J Intern Med; 2018 Jul; 33(4):649-659. PubMed ID: 29961307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoid Models of Human Gastrointestinal Development and Disease.
    Dedhia PH; Bertaux-Skeirik N; Zavros Y; Spence JR
    Gastroenterology; 2016 May; 150(5):1098-1112. PubMed ID: 26774180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoids derived from digestive tract, liver, and pancreas.
    Xu AT; Tong JL; Ran ZH
    J Dig Dis; 2016 Jan; 17(1):3-10. PubMed ID: 26666830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity-associated digestive cancers: A review of mechanisms and interventions.
    Zheng J; Zhao M; Li J; Lou G; Yuan Y; Bu S; Xi Y
    Tumour Biol; 2017 Mar; 39(3):1010428317695020. PubMed ID: 28351315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in gastrointestinal pathology.
    Garcia-Buitrago M; Montgomery EA
    Pathology; 2022 Mar; 54(2):145-146. PubMed ID: 35031085
    [No Abstract]   [Full Text] [Related]  

  • 18. CRISPR/Cas 9 genome editing and its applications in organoids.
    Driehuis E; Clevers H
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G257-G265. PubMed ID: 28126704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organoids for the Study of Liver Cancer.
    Wang H; Calvisi DF; Chen X
    Semin Liver Dis; 2021 Jan; 41(1):19-27. PubMed ID: 33764482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Knockout Gene-Edited Human Intestinal Organoids.
    Rajendra C; Wald T; Barber K; Spence JR; Fattahi F; Klein OD
    Methods Mol Biol; 2020; 2171():215-230. PubMed ID: 32705644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.